1020735

William H. Theodore — FEI 3013634984

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 8, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bethesda, MD (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance